Insider · CIK 0001870076
Peter Feinberg
director
Files at IMRX (Immuneering Corp). First filing Jun 23, 2025, latest Sep 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 0
$99k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | IMRXbuy Immuneering Corp | $36k 5,000 shares | +4% | - | |
| 44Moderate | Immuneering Corp | $63k 25,000 shares | +22% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +5,000 | $7.18 | $36k | 141,766 | Sep 30, 2025 |
| Jun 18, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +25,000 | $2.53 | $63k | 136,766 | Jun 23, 2025 |
| Jun 13, 2025 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +33,350 | $0.00 | $0 | 33,350 | Jun 16, 2025 |
| Jan 1, 2025 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +23,485 | $0.00 | $0 | 23,485 | Jan 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.